JP2022526651A5 - - Google Patents
Info
- Publication number
- JP2022526651A5 JP2022526651A5 JP2021559800A JP2021559800A JP2022526651A5 JP 2022526651 A5 JP2022526651 A5 JP 2022526651A5 JP 2021559800 A JP2021559800 A JP 2021559800A JP 2021559800 A JP2021559800 A JP 2021559800A JP 2022526651 A5 JP2022526651 A5 JP 2022526651A5
- Authority
- JP
- Japan
- Prior art keywords
- integer
- independently
- appearing
- compound according
- bond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024152056A JP2025000633A (ja) | 2019-04-11 | 2024-09-04 | プログラム可能なポリマー薬 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962832728P | 2019-04-11 | 2019-04-11 | |
| US62/832,728 | 2019-04-11 | ||
| US201962877160P | 2019-07-22 | 2019-07-22 | |
| US62/877,160 | 2019-07-22 | ||
| PCT/US2020/027758 WO2020210694A1 (en) | 2019-04-11 | 2020-04-10 | Programmable polymeric drugs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024152056A Division JP2025000633A (ja) | 2019-04-11 | 2024-09-04 | プログラム可能なポリマー薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022526651A JP2022526651A (ja) | 2022-05-25 |
| JP2022526651A5 true JP2022526651A5 (enExample) | 2024-07-11 |
| JP7551060B2 JP7551060B2 (ja) | 2024-09-17 |
Family
ID=70482851
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559800A Active JP7551060B2 (ja) | 2019-04-11 | 2020-04-10 | プログラム可能なポリマー薬 |
| JP2024152056A Pending JP2025000633A (ja) | 2019-04-11 | 2024-09-04 | プログラム可能なポリマー薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024152056A Pending JP2025000633A (ja) | 2019-04-11 | 2024-09-04 | プログラム可能なポリマー薬 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220168435A1 (enExample) |
| EP (1) | EP3952918A1 (enExample) |
| JP (2) | JP7551060B2 (enExample) |
| KR (1) | KR20210152522A (enExample) |
| CN (2) | CN120037399A (enExample) |
| WO (1) | WO2020210694A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3019559A4 (en) | 2013-08-22 | 2017-04-05 | Sony Corporation | Water soluble fluorescent or colored dyes and methods for their use |
| KR102646956B1 (ko) | 2015-02-26 | 2024-03-14 | 소니그룹주식회사 | 페닐에티닐나프탈렌 염료 및 이의 사용 방법 |
| WO2016138461A1 (en) | 2015-02-26 | 2016-09-01 | Sony Corporation | Water soluble fluorescent or colored dyes comprising conjugating groups |
| KR102765335B1 (ko) | 2015-05-11 | 2025-02-13 | 소니그룹주식회사 | 초휘도 이량체성 또는 중합체성 염료 |
| BR112018070164B1 (pt) | 2016-04-01 | 2022-09-27 | Sony Corporation Of America | Corantes diméricos ou poliméricos ultrabrilhantes |
| EP3436528B1 (en) | 2016-04-01 | 2025-07-02 | Sony Group Corporation | Ultra bright dimeric or polymeric dyes with rigid spacing groups |
| CN109153860B (zh) | 2016-04-06 | 2021-04-23 | 索尼公司 | 具有间隔连接体基团的超高亮二聚体或聚合物染料 |
| WO2017189805A1 (en) | 2016-04-27 | 2017-11-02 | Abbvie Inc. | Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies |
| BR112018073199A2 (pt) | 2016-05-11 | 2019-04-16 | Sony Corporation | corantes diméricos ou poliméricos ultrabrilhantes |
| WO2018022925A1 (en) | 2016-07-29 | 2018-02-01 | Sony Corporation | Ultra bright dimeric or polymeric dyes and methods for preparation of the same |
| KR20260011205A (ko) | 2017-10-05 | 2026-01-22 | 소니그룹주식회사 | 프로그램가능한 중합체성 약물 |
| US12290571B2 (en) | 2017-10-05 | 2025-05-06 | Sony Group Corporation | Programmable dendritic drugs |
| CN111836645A (zh) | 2017-11-16 | 2020-10-27 | 索尼公司 | 可编程的聚合药物 |
| US12076407B2 (en) | 2018-01-12 | 2024-09-03 | Sony Group Corporation | Polymers with rigid spacing groups comprising biologically active compounds |
| WO2019140128A1 (en) | 2018-01-12 | 2019-07-18 | Sony Corporation | Phosphoalkyl polymers comprising biologically active compounds |
| EP3737417B1 (en) | 2018-01-12 | 2025-08-27 | Sony Group Corporation | Phosphoalkyl ribose polymers comprising biologically active compounds |
| EP3769085B1 (en) | 2018-03-19 | 2022-08-24 | Sony Group Corporation | Use of divalent metals for enhancement of fluorescent signals |
| KR102864292B1 (ko) | 2018-03-21 | 2025-09-26 | 소니그룹주식회사 | 링커 군을 갖는 중합체성 텐덤 염료 |
| JP7580689B2 (ja) | 2018-06-27 | 2024-11-12 | ソニーグループ株式会社 | デオキシリボースを含むリンカー基を有するポリマー色素 |
| US12578342B2 (en) | 2018-07-13 | 2026-03-17 | Sony Group Corporation | Polymeric dyes having a backbone comprising organophosphate units |
| EP3861074A2 (en) | 2019-09-26 | 2021-08-11 | Sony Group Corporation | Polymeric tandem dyes with linker groups |
| EP4038081A1 (en) | 2019-09-30 | 2022-08-10 | Sony Group Corporation | Nucleotide probes |
| EP4256078A1 (en) | 2020-12-07 | 2023-10-11 | Sony Group Corporation | Spacing linker group design for brightness enhancement in dimeric or polymeric dyes |
| CN117750977A (zh) * | 2021-07-22 | 2024-03-22 | 索尼集团公司 | 聚合型药物的自动合成 |
| US20240350645A1 (en) * | 2021-07-22 | 2024-10-24 | Sony Group Corporation | Automated synthesis of polymeric drugs |
| EP4590340A1 (en) * | 2022-09-22 | 2025-07-30 | Sony Group Corporation | Polymers with steroids or vitamins |
| KR20250110263A (ko) * | 2022-11-22 | 2025-07-18 | 소니그룹주식회사 | 항신생물제를 포함하는 중합체 화합물 |
| CN121586588A (zh) | 2023-08-31 | 2026-02-27 | 富士胶片株式会社 | 靶向药物复合体及包含靶向药物复合体的药品以及化合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3019559A4 (en) | 2013-08-22 | 2017-04-05 | Sony Corporation | Water soluble fluorescent or colored dyes and methods for their use |
| WO2016138461A1 (en) | 2015-02-26 | 2016-09-01 | Sony Corporation | Water soluble fluorescent or colored dyes comprising conjugating groups |
| KR102765335B1 (ko) * | 2015-05-11 | 2025-02-13 | 소니그룹주식회사 | 초휘도 이량체성 또는 중합체성 염료 |
| JP6817288B2 (ja) * | 2015-08-10 | 2021-01-20 | ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． | 新規な連結体及び生体分子と薬物との特異的共役におけるその使用 |
| CN109153860B (zh) * | 2016-04-06 | 2021-04-23 | 索尼公司 | 具有间隔连接体基团的超高亮二聚体或聚合物染料 |
| BR112018073199A2 (pt) * | 2016-05-11 | 2019-04-16 | Sony Corporation | corantes diméricos ou poliméricos ultrabrilhantes |
| KR20260011205A (ko) * | 2017-10-05 | 2026-01-22 | 소니그룹주식회사 | 프로그램가능한 중합체성 약물 |
-
2020
- 2020-04-10 CN CN202510194215.XA patent/CN120037399A/zh active Pending
- 2020-04-10 JP JP2021559800A patent/JP7551060B2/ja active Active
- 2020-04-10 EP EP20723676.1A patent/EP3952918A1/en active Pending
- 2020-04-10 WO PCT/US2020/027758 patent/WO2020210694A1/en not_active Ceased
- 2020-04-10 KR KR1020217036842A patent/KR20210152522A/ko not_active Ceased
- 2020-04-10 US US17/602,718 patent/US20220168435A1/en active Pending
- 2020-04-10 CN CN202080040295.9A patent/CN114072178A/zh active Pending
-
2024
- 2024-09-04 JP JP2024152056A patent/JP2025000633A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022526014A5 (enExample) | ||
| JP2022526017A5 (enExample) | ||
| JP2024536224A5 (enExample) | ||
| JP2024537069A5 (enExample) | ||
| US20200247887A1 (en) | Anti-cd79b antibodies and immunoconjugates and methods of use | |
| WO2020210692A1 (en) | Programmable polymeric drugs | |
| CN120037399A (zh) | 可编程的聚合药物 | |
| EP3952916A1 (en) | Programmable polymeric drugs | |
| US7378091B2 (en) | Antibodies against carbonic anhydrase IX (CA IX) tumor antigen | |
| CN102580084B (zh) | Her抗体的固定剂量给药 | |
| JP5138867B2 (ja) | α−フェトタンパク質Ｉｍｍｕ３１抗体および融合タンパク質ならびにその使用方法 | |
| EP2611834B1 (en) | Rapid generation of anti-idiotypic antibodies | |
| JP2021510696A5 (enExample) | ||
| IL287292B (en) | and fusion antibody-drug-cd79b engineered antibodies cysteine- | |
| US20250009786A1 (en) | Automated synthesis of polymeric dual drugs | |
| JP2008523073A (ja) | Ｈｅｒ阻害剤を用いた治療のための患者の選択 | |
| NZ583318A (en) | Humanized anti-cd79b antibodies and immunoconjugates and methods of use | |
| EP4346909A1 (en) | Neodegrader conjugates | |
| WO2023052970A1 (en) | Pyrrolobenzodiazepine conjugates for cancer treatment | |
| JP2024532726A5 (enExample) | ||
| TWI913660B (zh) | 酶裂解連接子及包含其的配體-艾瑞布林偶聯物 | |
| US20240307548A1 (en) | Enhanced targeting using antibody-oligonucleotide conjugates | |
| EP4285936A1 (en) | Antibody-drug conjugate and medical use thereof | |
| CN114605536B (zh) | 降低抗人胸腺基质淋巴细胞生成素单克隆抗体生产中宿主细胞蛋白含量的亲和纯化方法 | |
| WO2024110803A1 (en) | Polymeric compounds comprising antineoplastic agents |